Company Announcements - *ST Zhengping has completed the stock suspension review and will resume trading on November 12, confirming normal production and operation without significant changes [1] - Upwind New Materials is in the product development stage for its embodied intelligent robot business, which has not yet achieved mass production or revenue generation [2] - Shannon Chip Innovation's fourth largest shareholder, Shenzhen Xinlianpu, has pledged 1.27 million shares for financing purposes [3] - Qing Shui Yuan's phosphorus trichloride products are primarily used in the production of water treatment agents [4] - Midea Group announced a cash dividend plan of 5 yuan per 10 shares, totaling 3.448 billion yuan, with the record date on November 17 [4] - Huiyuan Communication is planning a change of control, leading to a stock suspension starting November 12 [5] - Shen Gong Co. has clarified that some research reports on its performance forecasts represent only analysts' personal views [6] - World is developing diamond micro-drills for PCB processing, which are still in the R&D phase [6] - Haike New Source has signed an agreement with Kunlun New Materials for the purchase of 596,200 tons of electrolyte solvent [7] - Tongxing Technology plans to invest 3.2 billion yuan in a project to produce 100,000 tons of sodium battery cathode materials and 6 GWh battery cells [8] Investments & Contracts - Zhongjin Irradiation is investing 200 million yuan to build an electronic accelerator intelligent manufacturing project [10] - Hongri Da is collaborating with Te Du Technology and Hongke Tongchuang to establish a joint venture for semiconductor packaging [10] Shareholding Changes - Jian Kai Technology's controlling shareholder Xuanzhao plans to transfer 3% of its shares through a pricing inquiry [12] - Yue Wannianqing's shareholder Hehe Investment intends to reduce its stake by up to 3% [14] Financing & Capital Increase - Weiteng Electric plans to raise up to 300 million yuan through a private placement for various manufacturing projects [22] Other Developments - Zhifei Biological has received approval for clinical trials of a vaccine for adolescents and adults [23] - Shanghai Kaibao has obtained approval for clinical trials of a drug for acute ischemic stroke [24]

（编辑 任世碧） 证券日报网讯 11月11日晚间，键凯科技发布公告称，拟参与键凯科技首发前股东询价转让（简称"本次 询价转让"）的股东为XUANZHAO；出让方拟转让股份的总数为1，819，521股，占键凯科技总股本的 比例为3%；本次询价转让不通过集中竞价交易或大宗交易方式进行，不属于通过二级市场减持。受让 方通过询价转让受让的股份，在受让后6个月内不得转让；本次询价转让的受让方为具备相应定价能力 和风险承受能力的机构投资者。 ...

Key Points - *ST Zhengping's stock will resume trading on November 12, 2025, after a significant increase of 152.42% from September 1 to October 28, 2025, with 21 days of trading halts and 5 instances of abnormal trading fluctuations [3] - Dongfang Zhizao plans to acquire 70% of Nantong Saifu Machinery Equipment Co., Ltd. for 27.4887 million yuan, making it a subsidiary [4] - Zhifei Biology received approval for clinical trials of a combined vaccine for adolescents and adults to prevent diphtheria, tetanus, and whooping cough [5] - CITIC Securities has been approved by the CSRC to issue up to 50 billion yuan in short-term corporate bonds [6] - Bangji Technology intends to terminate a major asset restructuring involving the acquisition of several companies, stating that current operations will not be adversely affected [7] - Dekeli is planning to issue S-shares and list on the Singapore Exchange as part of its global strategy [8] - Emei Mountain A announced that Leshan State Investment will transfer 90% of its stake in Emei Mountain Leshan Buddha Tourism Group to another state-owned entity without compensation, maintaining the current control structure [9] Performance Summary - Xincheng Development reported a contract sales amount of approximately 1.419 billion yuan in October 2025, with cumulative sales of about 16.468 billion yuan from January to October [11] - Huadong Holdings sold 242,500 pigs in October 2025, with a 19.85% month-on-month increase and a 20.80% year-on-year increase [13] - Xiamen Airport's passenger throughput in October was 2.5548 million, a year-on-year increase of 1.56% [14] Shareholding Changes - Huaguang Huaneng executives plan to reduce their holdings, with the chairman and several executives intending to sell up to 171,200 shares each [16] - Hot景 Biology announced a share buyback plan of 100 million to 200 million yuan for employee stock ownership or incentives [17] - Aladdin's controlling shareholder's stake decreased from 46.27% to 44.76% due to the dissolution of a partnership [18] - JianKai Technology's controlling shareholder plans to transfer 3% of the company's shares [19] - Yuyuan Holdings intends to repurchase shares worth 200 million to 300 million yuan at a price not exceeding 8.6 yuan per share [20] Major Contracts - China Oil Engineering's subsidiary won a project in Kazakhstan worth approximately 3.003 billion yuan for the construction of ethane and propane pipelines [22] - Dash Intelligent signed a contract for an intelligent display technology park project worth 12.7652 million yuan, which will positively impact its market share in the enterprise park sector [24]

人民财讯11月11日电，键凯科技(688356)11月11日公告，公司持股24.54%的股东XUAN ZHAO拟询价转 让公司股份181.95万股，占键凯科技总股本的3%。此次询价转让的出让方系键凯科技的控股股东、实 控人、董事长及高级管理人员。 ...

格隆汇11月11日丨键凯科技(688356.SH)公布，公司拟参与键凯科技首发前股东询价转让（以下简称"本 次询价转让"）的股东为 XUAN ZHAO；出让方拟转让股份的总数为1,819,521股，占键凯科技总股本的 比例为3%。 ...

证券代码：688356 证券简称：键凯科技 公告编号：2025-037 北京键凯科技股份有限公司 股东询价转让计划书 股东 XUAN ZHAO（以下简称"出让方"）保证向北京键凯科技股份有限 公司（以下简称"键凯科技"）提供的信息内容不存在任何虚假记载、误导性陈 述或者重大遗漏，并对其真实性、准确性和完整性依法承担法律责任。 本公司及董事会全体成员保证公告内容与信息披露义务人提供的信息一致。 重要内容提示： 拟参与键凯科技首发前股东询价转让（以下简称"本次询价转让"）的 股东为 XUAN ZHAO； 出让方拟转让股份的总数为 1,819,521 股，占键凯科技总股本的比例为 3%； 管理人员，持有键凯科技股份比例超过 5%。 （三）出让方关于拟转让股份权属清晰、不存在限制或者禁止转让情形、 不存在违反相关规则及其作出的承诺的声明 本次询价转让不通过集中竞价交易或大宗交易方式进行，不属于通过二 级市场减持。受让方通过询价转让受让的股份，在受让后 6 个月内不得转让； 本次询价转让的受让方为具备相应定价能力和风险承受能力的机构投资 者。 一、拟参与转让的股东情况 （一）出让方的名称、持股数量、持股比例 出让方委托 ...

（北京市朝阳区安立路 66 号 4 号楼） 中信建投证券股份有限公司 关于北京键凯科技股份有限公司 股东向特定机构投资者询价转让股份 相关资格的核查意见 1 中信建投证券股份有限公司（以下简称"中信建投证券"）受北京键凯科技 股份有限公司（以下简称"键凯科技"）股东 XUAN ZHAO（以下简称"出让方"） 委托，组织实施本次键凯科技首发前股东向特定机构投资者询价转让（以下简称 "本次询价转让"）。 根据《关于在上海证券交易所设立科创板并试点注册制的实施意见》《科创 板上市公司持续监管办法（试行）》《上海证券交易所科创板股票上市规则》《上 海证券交易所科创板上市公司自律监管指引第 4 号——询价转让和配售》（以下 简称"《询价转让和配售指引》"）等相关规定，中信建投证券对参与本次询价转 让股东的相关资格进行核查，并出具本核查意见。 一、 本次询价转让的委托 中信建投证券收到出让方关于本次询价转让的委托，委托中信建投证券组织 实施本次询价转让。 二、 关于参与本次询价转让股东相关资格的核查情况 （一） 核查过程 根据相关法规要求，中信建投证券对出让方的相关资格进行了核查。出让方 已出具《关于向特定机构投资者询价 ...

智通财经APP讯，键凯科技(688356.SH)披露股东询价转让计划书，拟参与本次询价转让的股东为XUAN ZHAO，拟转让股份的总数为181.95万股，占公司总股本的比例为3%。 ...

键凯科技公告，股东XUAN ZHAO拟通过询价转让方式转让181.95万股，占公司总股本的3%。此次转让 不通过集中竞价交易或大宗交易进行，受让方为具备相应定价能力和风险承受能力的机构投资者，且受 让后6个月内不得转让。 ...

Core Viewpoint - JianKai Technology's stock price has shown significant volatility, with a year-to-date increase of 60.22%, but a recent decline in the last five trading days by 1.88% [2] Group 1: Stock Performance - As of November 11, JianKai Technology's stock price rose by 2.01% to 90.99 CNY per share, with a market capitalization of 5.519 billion CNY [1] - The stock has experienced a 6.11% increase over the past 20 days, while it has decreased by 9.19% over the last 60 days [2] - The company has appeared on the "Dragon and Tiger List" once this year, with a net buy of 39.1731 million CNY on July 21 [2] Group 2: Financial Performance - For the period from January to September 2025, JianKai Technology reported a revenue of 211 million CNY, reflecting a year-on-year growth of 13.47% [2] - The net profit attributable to the parent company for the same period was 40.7246 million CNY, marking a year-on-year increase of 24.72% [2] - Cumulatively, the company has distributed 178 million CNY in dividends since its A-share listing, with 99.8755 million CNY distributed over the last three years [3] Group 3: Shareholder Information - As of September 30, 2025, JianKai Technology had 6,608 shareholders, an increase of 23.19% from the previous period [2] - The average number of circulating shares per shareholder decreased by 18.83% to 9,178 shares [2] - Notably, CITIC JianKang A (002408) has exited the list of the top ten circulating shareholders [3]